Trial record 1 of 36 for:    Open Studies | "sexual dysfunction" women
Previous Study | Return to List | Next Study

The Impact of a Topical Vasodilating Cream on Female Sexual Experience (TVConFSD)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by East Suburban Ob Gyn.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
West Penn Allegheny Health System
Information provided by (Responsible Party):
Michael Pelekanos MD, East Suburban Ob Gyn
ClinicalTrials.gov Identifier:
NCT01078077
First received: March 1, 2010
Last updated: March 1, 2012
Last verified: March 2012
  Purpose

The purpose of this study is to determine if a topical vasodilating cream will improve female sexual experience.


Condition
Female Sexual Dysfunction

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: The Impact of a Topical Vasodilating Cream (When Applied to the Clitoris) on the Female Sexual Experience Using a Standard 7 Part Female Sexual Dysfunction Questionnaire

Further study details as provided by East Suburban Ob Gyn:

Estimated Enrollment: 200
Study Start Date: March 2010
Estimated Study Completion Date: July 2012
Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)
Detailed Description:

To determine in a placebo controlled double blinded study whether a topically applied vasodilating cream will improve the female sexual response as measured by a standard female sexual dysfunction questionnaire

  Eligibility

Ages Eligible for Study:   25 Years to 60 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Sexually active females from ages 25 to sixty not on SSRI's without neurologic disease able sign and understand informed consent

Criteria

Inclusion Criteria:

  • Healthy females ages 25 to sixty sexually active

Exclusion Criteria:

  • Neurologic disease, on SSRI's,advanced diabetes, non sexually active, mentally incompetent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01078077

Contacts
Contact: michael j pelekanos, MD 4128567500 mipels@aol.com
Contact: Guy Stofman, MD 4123706313 guystof@aol.com

Locations
United States, Pennsylvania
West Penn Allegheny Health Center Recruiting
Monroeville, Pennsylvania, United States, 15146
Contact: pelekanos    412-856-7500      
Contact: vickie lathom    4128567500      
Principal Investigator: michael j pelekanos, md         
West Penn Hospital Forbes Campus Recruiting
Monroeville, Pennsylvania, United States, 15146
Contact: michael j pelekanos, md    412-856-7500    mipels@aol.com   
Principal Investigator: michael j pelekanos, md         
East Suburban Obgyn Recruiting
Monroeville, Pennsylvania, United States, 15146
Contact: Michael J Pelekanos, MD    412-779-1034    mipels@aol.com   
Contact: Guy Stoffman, MD    412 3706313    guystof@aol.com   
Principal Investigator: Michael J Pelekanos, MD         
Sponsors and Collaborators
Michael Pelekanos MD
West Penn Allegheny Health System
Investigators
Principal Investigator: michael j pelekanos, MD east surburban obgyn
  More Information

No publications provided

Responsible Party: Michael Pelekanos MD, michael pelekanos MD, WPAHS, East Suburban Ob Gyn
ClinicalTrials.gov Identifier: NCT01078077     History of Changes
Other Study ID Numbers: 10-005
Study First Received: March 1, 2010
Last Updated: March 1, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by East Suburban Ob Gyn:
healthy females ages twentyfive through sixty

ClinicalTrials.gov processed this record on August 28, 2014